Expression and correlation of Bcl-2 with pathological grades in human glioma stem cells

Oncology Reports

Volumn 28, Issue 1, 2012, Pages 155-160

  Qiu, Bo ^a   Wang, Yong ^a   Tao, Jun ^a   Wang, Yunjie ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Bcl 2; Brain glioma stem cells; Glioma; Therapy

Indexed keywords

PROTEIN BCL 2;

APOPTOSIS; ARTICLE; B CELL LYMPHOMA; CANCER GRADING; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOASSAY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; UPREGULATION;

ANTIGENS, CD; BRAIN NEOPLASMS; CELL PROLIFERATION; GLIOMA; GLYCOPROTEINS; HUMANS; NEOPLASTIC STEM CELLS; PEPTIDES; PROTO-ONCOGENE PROTEINS C-BCL-2; REAL-TIME POLYMERASE CHAIN REACTION; SPHEROIDS, CELLULAR; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 84861535742     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1800     Document Type: Article

References (51)

1. Bondy ML, Scheurer ME, Malmer B, et al: Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer 113: 1953-1968, 2008.
2. Deltour I, Johansen C, Auvinen A, Feychting M, Klaeboe L and Schuz J: Time trends in brain tumor incidence rates in Denmark, Finland, Norway, and Sweden, 1974-2003. J Natl Cancer Inst 101: 1721-1724, 2009.
3. Stupp R, Hegi ME, Mason WP, et al: Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10: 459-466, 2009.
4. Doucette TA and Rao G: B-cell lymphoma-2 promotes malignant progression in glioma. Clin Neurosurg 58: 149-154, 2011.
5. Tagscherer KE, Fassl A, Campos B, et al: Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins. Oncogene 27: 6646-6656, 2008.
6. Debien E, Hervouet E, Gautier F, Juin P, Vallette FM and Cartron PF: ABT-737 and/or folate reverse the PDGF-induced alterations in the mitochondrial apoptotic pathway in low-grade glioma patients. Clin Epigenetics 2: 369-381, 2011.
7. Jiang Z, Zheng X and Rich KM: Down-regulation of Bcl-2 and Bcl-xL expression with bispecific antisense treatment in glioblastoma cell lines induce cell death. J Neurochem 84: 273-281, 2003. (Pubitemid 36182269)
8. Bao S, Wu Q, McLendon RE, et al: Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444: 756-760, 2006. (Pubitemid 44949604)
9. Galli R, Binda E, Orfanelli U, et al: Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 64: 7011-7021, 2004. (Pubitemid 39331011)
10. Singh S and Dirks PB: Brain tumor stem cells: identification and concepts. Neurosurg Clin North Am 18: 31-38, 2007. (Pubitemid 46161197)
11. Singh SK, Clarke ID, Terasaki M, et al: Identification of a cancer stem cell in human brain tumors. Cancer Res 63: 5821-5828, 2003. (Pubitemid 37187480)
12. Wang R, Chadalavada K, Wilshire J, et al: Glioblastoma stem-like cells give rise to tumour endothelium. Nature 468: 829-833, 2010.
13. Venere M, Fine HA, Dirks PB and Rich JN: Cancer stem cells in gliomas: identifying and understanding the apex cell in cancer's hierarchy. Glia 59: 1148-1154, 2011.
14. Dean M, Fojo T and Bates S: Tumour stem cells and drug resistance. Nat Rev Cancer 5: 275-284, 2005. (Pubitemid 40488633)
15. Binello E and Germano IM: Targeting glioma stem cells: a novel framework for brain tumors. Cancer Sci 102: 1958-1966, 2011.
16. Yuan X, Curtin J, Xiong Y, et al: Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 23: 9392-9400, 2004. (Pubitemid 40069671)
17. Gilbert CA and Ross AH: Cancer stem cells: cell culture, markers, and targets for new therapies. J Cell Biochem 108: 1031-1038, 2009.
18. + cancer stem cells in glioblastoma. Mol Cancer 5: 67, 2006.
19. Reynolds BA and Weiss S: Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255: 1707-1710, 1992.
20. Hemmati HD, Nakano I, Lazareff JA, et al: Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci USA 100: 15178-15183, 2003. (Pubitemid 37518036)
21. + glioma cells: possible targets of immunotherapy. J Neurooncol 83: 121-131, 2007.
22. Qiu B, Zhang D, Wang C, et al: IL-10 and TGF-beta2 are overexpressed in tumor spheres cultured from human gliomas. Mol Biol Rep 38: 3585-3591, 2011.
23. Qiu B, Zhang D, Tao J, Wu A and Wang Y: A simplified and modified procedure to culture brain glioma stem cells from clinical specimens. Oncol Lett 3: 50-54, 2012.
24. Yew DT, Wang HH and Zheng DR: Apoptosis in astrocytomas with different grades of malignancy. Acta Neurochir (Wien) 140: 341-347, 1998. (Pubitemid 28256541)
25. Ambroise MM, Khosla C, Ghosh M, Mallikarjuna VS and Annapurneswari S: The role of immunohistochemistry in predicting behavior of astrocytic tumors. Asian Pac J Cancer Prev 11: 1079-1084, 2010.
26. Takekawa Y, Sawada T and Sakurai I: Expression of apoptosis and its related protein in astrocytic tumors. Brain Tumor Pathol 16: 11-16, 1999.
27. Nakasu S, Nakasu Y, Nioka H, Nakajima M and Handa J: bcl-2 protein expression in tumors of the central nervous system. Acta Neuropathol 88: 520-526, 1994. (Pubitemid 24364699)
28. Newcomb EW, Bhalla SK, Parrish CL, Hayes RL, Cohen H and Miller DC: bcl-2 protein expression in astrocytomas in relation to patient survival and p53 gene status. Acta Neuropathol 94: 369-375, 1997. (Pubitemid 27450118)
29. Jukich PJ, McCarthy BJ, Surawicz TS, Freels S and Davis FG: Trends in incidence of primary brain tumors in the United States, 1985-1994. Neurooncology 3: 141-151, 2001. (Pubitemid 33674105)
30. Deorah S, Lynch CF, Sibenaller ZA and Ryken TC: Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001. Neurosurg Focus 20: E1, 2006.
31. Pirouzmand F and Sadanand V: The incidence trends of primary brain tumors in Saskatchewan from 1970 to 2001. Can J Neurol Sci 34: 181-186, 2007. (Pubitemid 47000120)
32. Hess KR, Broglio KR and Bondy ML: Adult glioma incidence trends in the United States, 1977-2000. Cancer 101: 2293-2299, 2004. (Pubitemid 39458686)
33. Angileri FF, Aguennouz M, Conti A, et al: Nuclear factor-kappaB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas. Cancer 112: 2258-2266, 2008. (Pubitemid 351628637)
34. Agostini M, Tucci P and Melino G: Cell death pathology: perspective for human diseases. Biochem Biophys Res Commun 414: 451-455, 2011.
35. Steinbach JP and Weller M: Apoptosis in gliomas: molecular mechanisms and therapeutic implications. J Neurooncol 70: 247-256, 2004.
36. Bogler O and Weller M: Apoptosis in gliomas, and its role in their current and future treatment. Front Biosci 7: E339-E353, 2002.
37. Green DR and Reed JC: Mitochondria and apoptosis. Science 281: 1309-1312, 1998. (Pubitemid 28406816)
38. Malla R, Gopinath S, Alapati K, et al: Downregulation of uPAR and cathepsin B induces apoptosis via regulation of Bcl-2 and Bax and inhibition of the PI3K/Akt pathway in gliomas. PLoS One 5: e13731, 2010.
39. Brunelle JK and Letai A: Control of mitochondrial apoptosis by the Bcl-2 family. J Cell Sci 122: 437-441, 2009.
40. Adams JM and Cory S: Life-or-death decisions by the Bcl-2 protein family. Trends Biochem Sci 26: 61-66, 2001. (Pubitemid 32124712)
41. Adams JM and Cory S: The Bcl-2 protein family: arbiters of cell survival. Science 281: 1322-1326, 1998. (Pubitemid 28406819)
42. Yip KW and Reed JC: Bcl-2 family proteins and cancer. Oncogene 27: 6398-6406, 2008.
43. Bruggers CS, Fults D, Perkins SL, Coffin CM and Carroll WL: Coexpression of genes involved in apoptosis in central nervous system neoplasms. J Pediatr Hematol Oncol 21: 19-25, 1999. (Pubitemid 29131989)
44. Strik H, Deininger M, Streffer J, et al: Bcl-2 family protein expression in initial and recurrent glioblastomas: modulation by radiochemotherapy. J Neurol Neurosurg Psychiatry 67: 763-768, 1999.
45. Fels C, Schafer C, Huppe B, et al: Bcl-2 expression in higher-grade human glioma: a clinical and experimental study. J Neurooncol 48: 207-216, 2000.
46. Beier D, Hau P, Proescholdt M, et al: CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res 67: 4010-4015, 2007. (Pubitemid 46815044)
47. Bleau AM, Hambardzumyan D, Ozawa T, et al: PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. Cell Stem Cell 4: 226-235, 2009.
48. Shervington A and Lu C: Expression of multidrug resistance genes in normal and cancer stem cells. Cancer Invest 26: 535-542, 2008. (Pubitemid 351892589)
49. Wang J, Wakeman TP, Lathia JD, et al: Notch promotes radioresistance of glioma stem cells. Stem Cells 28: 17-28, 2010.
50. Weller M, Malipiero U, Aguzzi A, Reed JC and Fontana A: Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation. J Clin Invest 95: 2633-2643, 1995.
51. Lamszus K and Gunther HS: Glioma stem cells as a target for treatment. Target Oncol 5: 211-215, 2010.